Protective Effects of Antcin H Isolated from Antrodia cinnamomea Against Neuroinflammation in Huntington’s Disease via NLRP3 Inflammasome Inhibition

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Journal of Neuroimmune Pharmacology

• Publication date

  2024-12-02

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s11481-024-10161-7PMID 39621196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deletion of equilibrative nucleoside transporter 2 disturbs energy metabolism and exacerbates disease progression in an experimental model of Huntington's disease.

  2023cited by this paper
• Neuronal NLRP3 inflammasome mediates spreading depolarization-evoked trigeminovascular activation.

  2023cited by this paper
• A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington’s disease

  2022influential reference
• Emerging Role of NLRP3 Inflammasome/Pyroptosis in Huntington’s Disease

  2022cited by this paper
• Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway

  2021cited by this paper
• Pyroptotic cell death in the R6/2 mouse model of Huntington’s disease: new insight on the inflammasome

  2020cited by this paper
• Antrodia Cinnamomea Attenuates Non-Alcoholic Steatohepatitis by Suppressing NLRP3 Inflammasome Activation In Vitro and In Vivo.

  2020cited by this paper
• A mechanistic and empirical review of antcins, a new class of phytosterols of formosan fungi origin.

  2020influential reference
• Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington’s disease

  2019cited by this paper
• Aggregated Tau activates NLRP3–ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo

  2019cited by this paper
• Amyloid β directly interacts with NLRP3 to initiate inflammasome activation: identification of an intrinsic NLRP3 ligand in a cell-free system

  2018cited by this paper
• MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration

  2018cited by this paper
• The JAK inhibitor antcin H exhibits direct anticancer activity while enhancing chemotherapy against LMP1-expressed lymphoma

  2018cited by this paper
• Antcin H Protects Against Acute Liver Injury Through Disruption of the Interaction of c-Jun-N-Terminal Kinase with Mitochondria

  2017cited by this paper
• 4,7-Dimethoxy-5-methyl-1,3-benzodioxole from Antrodia camphorata inhibits LPS-induced inflammation via suppression of NF-κB and induction HO-1 in RAW264.7 cells.

  2016cited by this paper
• AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.

  2014cited by this paper
• The medicinal fungus Antrodia cinnamomea suppresses inflammation by inhibiting the NLRP3 inflammasome.

  2014cited by this paper
• Ginsenoside Rg3 Alleviates Lipopolysaccharide-Induced Learning and Memory Impairments by Anti-Inflammatory Activity in Rats

  2013cited by this paper
• Triggering of Inflammasome by Aggregated α–Synuclein, an Inflammatory Response in Synucleinopathies

  2013cited by this paper
• Assessing β-amyloid-induced NLRP3 inflammasome activation in primary microglia.

  2013cited by this paper
• A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.

  2013cited by this paper
• Recent research and development of Antrodia cinnamomea.

  2013cited by this paper
• Current evidence for the hepatoprotective activities of the medicinal mushroom Antrodia cinnamomea

  2013cited by this paper
• Microglia

  2013cited by this paper
• Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease.

  2013cited by this paper
• Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons.

  2012cited by this paper
• Protective Effects of Antrodia Cinnamomea Against Liver Injury

  2012cited by this paper
• Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease

  2011influential reference
• Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation.

  2011cited by this paper
• Dysregulated brain creatine kinase is associated with hearing impairment in mouse models of Huntington disease.

  2011cited by this paper
• The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease.

  2010cited by this paper
• Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases.

  2009cited by this paper
• Ginsenosides protect striatal neurons in a cellular model of Huntington's disease

  2009cited by this paper
• Microglial physiology: unique stimuli, specialized responses.

  2009cited by this paper
• The NALP3 inflammasome is involved in the innate immune response to amyloid-β

  2008cited by this paper
• Faculty Opinions recommendation of The NALP3 inflammasome is involved in the innate immune response to amyloid-beta.

  2008cited by this paper
• Tetrabenazine in the treatment of Huntington’s disease

  2007cited by this paper
• Dysregulation of C/EBPα by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease

  2007cited by this paper
• Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease

  2007cited by this paper
• Dysregulation of C/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease.

  2007cited by this paper
• SQ/TQ cluster domains: concentrated ATM/ATR kinase phosphorylation site regions in DNA‐damage‐response proteins

  2005cited by this paper
• Protective effects of ginseng components in a rodent model of neurodegeneration

  2005cited by this paper
• Huntingtin and the molecular pathogenesis of Huntington's disease

  2004cited by this paper
• Microglia

  2004cited by this paper
• Oxidative damage in Huntington's disease.

  2004cited by this paper
• DNA damage induced by polyglutamine-expanded proteins.

  2003cited by this paper
• Inhibitory effect of ginsenosides on NMDA receptor-mediated signals in rat hippocampal neurons.

  2002cited by this paper
• The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.

  2002cited by this paper
• Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.

  2001cited by this paper
• Huntingtin Aggregate-Associated Axonal Degeneration is an Early Pathological Event in Huntington's Disease Mice

  2001cited by this paper
• Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease.

  2000cited by this paper
• Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse

  2000cited by this paper
• Increased Vulnerability to 3‐Nitropropionic Acid in an Animal Model of Huntington's Disease

  1998cited by this paper
• Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates

  1998cited by this paper
• Ginsenosides Rb1and Rg3protect cultured rat cortical cells from glutamate‐induced neurodegeneration

  1998cited by this paper
• The interleukin-1 beta converting enzyme family of cysteine proteases.

  1997cited by this paper
• Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14.

  1996cited by this paper
• Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages.

  1996cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Huntington's disease. Pathogenesis and management.

  1986cited by this paper
• Neuropathological Classification of Huntington's Disease

  1985cited by this paper
• Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.

  1983cited by this paper
• Medicine

  1894cited by this paper

• Programmed cell death pathways in Huntington’s disease: spotlight on ferroptosis and pyroptosis

  2026cites this paper
• Targeting non-apoptotic regulated cell death (RCD) to treat neurodegenerative diseases

  2026cites this paper
• Mitochondrial oxidative stress to PANoptosis: Current evidence and therapeutic implications for neurological diseases.

  2026cites this paper
• Animal Models for the Study of Neurological Diseases and Their Link to Sleep

  2025cites this paper